← All indications
Tardive Dyskinesia
Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).
Drugs by status
Approved for this indication (3)
Phase 4 trials (4)
Phase 3 trials (6)
Phase 2 trials (4)
Phase 1 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (10)
Organization Involved with Other Experimental Indications (3)